supp.fit

Glucomannan: study protocols

27 study groups say how much Glucomannan participants took a day. These are the doses the studies gave. They are not a recommendation.

Glucomannan: what the research found →

Dose per serving from products

99 products in our catalogue print how much Glucomannan a serving holds.

Most common: 1 g to 2.5 g, 22% of 99 products.

Dose per servingProducts
25 mg or less
1
25 mg to 50 mg
20
50 mg to 100 mg
10
100 mg to 250 mg
19
250 mg to 500 mg
13
500 mg to 1 g
14
1 g to 2.5 g
22

Dose per serving from research

26 study groups in 20 studies say how much Glucomannan participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 62% of 26 study groups.

Daily doseStudy groups
1 g or less
2
1 g to 2.5 g
6
2.5 g to 5 g
16
5 g to 10 g
2

Commonly used together

7 of 27 study groups took Glucomannan with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Inulin
3

27 study groups

Study
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial
1995 · Rifaximin group · Outpatients with symptomatic uncomplicated diverticular disease of the colon
2 g1 year84
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial
1995 · Placebo group · Outpatients with symptomatic uncomplicated diverticular disease of the colon
2 g1 year84
[Use of glucomannan dietary fiber in changes in intestinal habit]
1995 · Glucomannan 3 gr/day · Patients; age and sex not reported; condition not specified
3 g5 weeks—
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon
2003 · Fiber supplementation with glucomannan plus rifaximin · Outpatients with uncomplicated symptomatic diverticular disease
4 g1 year558
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon
2003 · Glucomannan alone · Outpatients with uncomplicated symptomatic diverticular disease
4 g1 year346
Fiber (glucomannan) is beneficial in the treatment of childhood constipation
2004 · fiber (glucomannan) · Children aged 4.5–11.7 years with functional constipation, with or without encopresis
100 mg/kg4 weeks31
[Chronic use of glucomannan in the dietary treatment of severe obesity]
1992 · diet + glucomannan group · Severely obese patients; age and sex not stated
4 g90 days25
Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults
2006 · KGM-supplemented period · Healthy adults; age and sex not specified
4.5 g3 weeks8
Supplementation of konjac glucomannan into a low-fiber Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: a placebo-controlled, diet-controlled trial
2008 · KGM-supplemented period · Constipated adults who passed a bowel movement less than once a day; age range and sex not specified
4.5 g3 weeks7
Gummies candy enriched with Konjac glucomannan reduces hunger intensity and waist circumference of overweight individuals
2023 · KGM-enriched gummy candy · Overweight adults aged 18–45 years; sex not specified
250 mg2 weeks—
[Use of glucomannan dietary fiber in changes in intestinal habit]
1995 · Glucomannan 4 gr/day · Patients; age and sex not reported; condition not specified
4 g5 weeks—
Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk
2007 · soluble fiber group · overweight and obese men with BMI 25–35 kg/m²
3 g12 weeks15
The Impact of Glucomannan, Inulin, and Psyllium Supplementation (Soloways(TM)) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial
2024 · glucomannan, inulin, and psyllium · Adults aged 40–60 with BMI of at least 25 and at least one minor allele in a specified FTO, LEP, LEPR, or MC4R polymorphism
3 g180 days75
Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity
2008 · treatment group · Adults with obesity, BMI 30.0–39.9 kg/m²; sex and age range not reported
1.5 g12 weeks32
Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial
2008 · b.i.d. group · Overweight or obese patients; age and sex not specified
2 g16 weeks—
Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial
2008 · t.i.d. group · Overweight or obese patients; age and sex not specified
3 g16 weeks—
Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes
2006 · glucomannan · Adults aged 38–74 years, mildly hypercholesterolemic, with or without type II diabetes
10 g3 weeks34
Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Cinnamomum zeylanicum Blume and Inulin in Patients with Metabolic Syndrome
2024 · oral supplement group · Adults over 18 with overweight and metabolic syndrome, including people with type 2 diabetes or impaired glucose tolerance; men and women
1 g16 weeks29
Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men
1995 · konjac glucomannan (GM) · healthy men
3.9 g4 weeks63
Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects--a randomized double-blind trial
2003 · konjac glucomannan (KGM) supplement · Adults with hyperlipidemic type 2 diabetes; mean age 64.2 years, mean BMI 25.5 kg/m²
3.6 g4 weeks22
Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus
2007 · glucomannan intervention · Adults with type 2 diabetes mellitus; 10 men and 10 women
3 g4 weeks20
Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults
2017 · 98 g HFF + 2 g KM · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers
2 g1 day13
The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism
2007 · Group I · Newly diagnosed adults with hyperthyroidism, including patients with Graves' disease or multinodular goitre; age and sex not reported
2.6 g60 days—
Efficacy of different fibres and flour mixes in South-Asian flatbreads for reducing post-prandial glucose responses in healthy adults
2017 · 96 g HFF + 4 g KM · Apparently healthy adults; mean age 37 ± 9 years; 3 men and 35 women among completers
4 g1 day13
Ameliorative effects of konjac glucomannan on human faecal β-glucuronidase activity, secondary bile acid levels and faecal water toxicity towards Caco-2 cells
2011 · konjac glucomannan · Adult volunteers consuming a low-fibre diet; no condition stated
4.5 g4 weeks—
Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes
2006 · combination of glucomannan and plant sterols · Adults aged 38–74 years, mildly hypercholesterolemic, with or without type II diabetes
10 g3 weeks34
Relationship between the Peroxidation of Leukocytes Index Ratio and the Improvement of Postprandial Metabolic Stress by a Functional Food
2016 · HFHCM + Snello cookie (HFHCM-S) · Healthy men and women aged 25–50 years
2.4 g1 day10